|
Video: What is a Stock Split?
|
|
ADMA BIOLOGICS, INC. is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Co.'s products include: BIVIGAM, an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV, an IVIG product indicated for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B. According to our ADMA Biologics stock split history records, ADMA Biologics has had 0 splits. | |
|
ADMA Biologics (ADMA) has 0 splits in our ADMA Biologics stock split history database.
Looking at the ADMA Biologics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ADMA Biologics shares, starting with a $10,000 purchase of ADMA, presented on a split-history-adjusted basis factoring in the complete ADMA Biologics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$8.35 |
|
End price/share: |
$6.74 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-19.28% |
|
Average Annual Total Return: |
-2.12% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,071.70 |
|
Years: |
10.00 |
|
|
|
|
|